Related by context. Frequent words. (Click for all words.) 66 EORTC 66 RTOG 65 randomized Phase III 61 CATIE 61 multicenter clinical 60 neoadjuvant 60 National Surgical Adjuvant 60 phase IIa 59 substudy 59 decitabine 59 multicenter 59 neoadjuvant chemotherapy 59 multicentre 58 multicenter randomized 58 randomized clinical 58 retrospective cohort study 57 axitinib 57 randomized controlled clinical 57 dasatinib 57 subgroup analyzes 57 Phase Ib 57 Pharmacokinetic 57 tocilizumab 57 Phase III randomized 57 COPAXONE R 57 Cooperative Oncology 57 metastatic renal cell carcinoma 56 Phase 2a trial 56 temsirolimus 56 multicenter study 56 J Clin Oncol 56 ECOG 56 CAPRISA 56 Taxotere ® 56 sunitinib 56 PXD# 56 gefitinib 55 bortezomib 55 Phase Ia 55 Recurrence Score 55 aflibercept 55 adjuvant chemotherapy 55 NSCLC 55 Phase 1b trial 55 tesmilifene 55 NCI 55 hepatocellular carcinoma HCC 55 erlotinib 55 Phase 1b clinical 55 noninferiority 55 randomized clinical trials 54 HCV infected 54 cetuximab 54 evaluable patients 54 pemetrexed 54 BAY #-# 54 fondaparinux 54 Phase 2b study 54 placebo controlled randomized 54 azacitidine 54 Phase 1b 54 dose escalation trial 54 anastrozole 54 randomized controlled 54 PROPEL 54 EGFR mutations 54 COPAXONE ® 54 IMGN# 54 pharmacodynamic 54 seliciclib 54 pazopanib 53 randomized placebo controlled 53 randomized 53 FDG PET 53 sorafenib 53 ADXS# 53 ticagrelor 53 BMS # 53 bevacizumab 53 gemcitabine 53 trastuzumab 53 randomized trials 53 LymphoStat B 53 phase IIb 53 multicenter randomized double 53 androgen independent 53 prospective randomized 53 Phase 2a clinical 53 ASCO Annual Meeting 53 evaluable 53 genotypic 53 MDV# 53 FOLFIRI 53 castration resistant prostate cancer 53 antitumor activity 53 vandetanib 53 IMC A# 53 vicriviroc 53 HGS ETR1 53 Phase 2b trial 53 CA4P